Biochemical mechanisms involved in the β-blocker-induced changes in serum lipoproteinsLIJNEN, P.The American heart journal. 1992, Vol 124, Num 2, pp 549-556, issn 0002-8703Article

Cellular and humoral effects of naftopidil in manLIJNEN, P.Methods and findings in experimental and clinical pharmacology. 1992, Vol 14, Num 3, pp 211-217, issn 0379-0355Article

RADIOIMMUNOLOGICAL DETERMINATION OF 4-PREGNENE, -11BETA , 21-DIOL-3, 18, 20-TRIONE (ALDOSTERONE) IN PLASMA.LIJNEN P; AMERY A.1978; BULL. SOC. CHIM. BELGES; BELG.; DA. 1978; VOL. 87; NO 1; PP. 15-20; BIBL. 23 REF.Article

In vitro effect of naftopidil A novel α-adrenergic antagonist on cation transport systems in human erythrocytes, leukocytes and plateletsLIJNEN, P.Methods and findings in experimental and clinical pharmacology. 1991, Vol 13, Num 1, pp 29-36, issn 0379-0355, 8 p.Article

Alterations in sodium metabolism as an etiological model for hypertensionLIJNEN, P.Cardiovascular drugs and therapy. 1995, Vol 9, Num 3, pp 377-399, issn 0920-3206Article

ANGIOTENSINE CONVERTING ENZYME: ALGEMENE BEGRIPPEN = ENZYME DE CONVERSION DE L'ANGIOTENSINE: GENERALITESLIJNEN P; AMERY A; FAGARD R et al.1979; ACTA TUBERC. PNEUMOL. BELG.; BEL; DA. 1979; VOL. 70; NO 1; PP. 107-115; ABS. ENG/FRE; BIBL. 8 REF.Article

ANGIOTENSIN II AND SODIUM AS DETERMINANTS OF THE AGONISTIC-ANTAGONISTIC BALANCE OF SARALASIN'S ACTIONSFAGARD R; AMERY A; LIJNEN P et al.1981; CLIN. SCI. (1979); ISSN 0143-5221; GBR; DA. 1981; VOL. 60; NO 4; PP. 377-385; BIBL. 2 P.Article

Proliferation of human peripheral blood mononuclear cells during calcium entry blockade. Role of protein kinase CLIJNEN, P; PETROV, V.Methods and findings in experimental and clinical pharmacology. 1999, Vol 21, Num 4, pp 253-259, issn 0379-0355Article

Atrial natriuretic peptide II and III stimulation of Na⁺/H⁺ exchange in human erythrocytesLIJNEN, P; PETROV, V.Methods and findings in experimental and clinical pharmacology. 1995, Vol 17, Num 1, pp 5-13, issn 0379-0355Article

AN UNUSUAL CASE OF HYPERTENSION WITH HYPOKALAEMIAFAGARD R; GEUTJENS L; LIJNEN P et al.1982; ACTA CARDIOL.; ISSN 0001-5385; BEL; DA. 1982; VOL. 37; NO 2; PP. 147-150; BIBL. 5 REF.Article

BIOLOGICAL SIGNIFICANCE OF ACTIVE AND INACTIVE RENIN IN MANLIJNEN P; AMERY A; FAGARD R et al.1980; J. ENDOCRINOL.; GBR; DA. 1980; VOL. 85; NO 1; PP. 137-143; BIBL. 1 P.Article

HYPOTENSIVE EFFECTS OF SODIUM VOLUME DEPLETION AND 2-SAR-8-ALA-ANGIOTENSIN II IN RELATION TO PLASMA RENIN IN HYPERTENSIVE PATIENTS.FAGARD R; AMERY A; LIJNEN P et al.1977; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1977; VOL. 12; NO 1; PP. 1-5; BIBL. 13 REF.Article

DRIEVOUDIGE ANTIHYPERTENSIVE BEHANDELING. = THERAPEUTIQUE ANTI-HYPERTENSIVE TRIPLEAMERY A; FAGARD R; LIJNEN P et al.1976; ACTA CLIN. BELG.; BELG.; DA. 1976; VOL. 31; NO 5; PP. 266-277; ABS. FR. ANGL.; BIBL. 16 REF.Article

Transforming growth Factory-β₁-Induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblastsLIJNEN, P; PETROV, V.Methods and findings in experimental and clinical pharmacology. 2002, Vol 24, Num 6, pp 333-344, issn 0379-0355Article

DISCRIMINATION OF RENOVASCULAR FROM ESSENTIAL HYPERTENSION BY CONVERTING ENZYME INHIBITION WITH AN ORALLY ACTIVE COMPOUNDFAGARD R; AMERY A; LIJNEN P et al.1982; ACTA CLIN. BELG.; ISSN 0001-5512; BEL; DA. 1982; VOL. 37; NO 1; PP. 13-22; ABS. FRE/DUT; BIBL. 32 REF.Article

PLASMA PROSTAGLANDINS, RENIN, AND CATECHOLAMINES AT REST AND DURING EXERCISE IN HYPERTENSIVE HUMANSLIJNEN P; FAGARD R; STAESSEN J et al.1982; J. APPL. PHYSIOL.: RESPIR. ENVIRON. EXERC. PHYSIOL.; ISSN 0161-7567; USA; DA. 1982; VOL. 53; NO 4; PP. 891-894; BIBL. 27 REF.Article

PLASMA ANGIOTENSINE-CONVERTING ENZYME BIJ LONGTUBERCULOSE EN TUBERCULEUZE PLEURITIS = ENZYME CONVERTISSANT L'ANGIOTENSINE DU PLASMA DANS LA TUBERCULOSE PULMONAIRE ET LA PLEURITE TUBERCULEUSEDERVEAUX L; DEMEDTS M; LIJNEN P et al.1979; ACTA TUBERC. PNEUMOL. BELG.; BEL; DA. 1979; VOL. 70; NO 1; PP. 125-132; ABS. ENG/FRE; BIBL. 15 REF.Article

RELATIONSHIP BETWEEN BLOOD LEVEL OF ATENOLOL AND PHARMACOLOGIC EFFECT.AMERY A; DE PLAEN JP; LIJNEN P et al.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 21; NO 6; PP. 691-699; BIBL. 13 REF.Article

RELATIVE VALUE OF BETA BLOCKERS AND THIAZIDES FOR INITIATING ANTIHYPERTENSIVE THERAPY. BETA BLOCKERS OR THIAZIDES IN HYPERTENSION.FAGARD R; AMERY A; DE PLAEN JF et al.1976; ACTA CARDIOL.; BELG.; DA. 1976; VOL. 31; NO 5; PP. 411-426; ABS. FR. ESP.; BIBL. 2 P.Article

Inhibition of proliferation of human peripheral blood mononuclear cells by calcium antagonists. role of interleukin-2PETROV, V; LIJNEN, P.Methods and findings in experimental and clinical pharmacology. 2000, Vol 22, Num 1, pp 19-23, issn 0379-0355Article

Antagonism of the renin-angiotensin-aldosterone system and collagen metabolism in cardiac fibroblastsLIJNEN, P; PETROV, V.Methods and findings in experimental and clinical pharmacology. 1999, Vol 21, Num 3, pp 215-227, issn 0379-0355Article

Modification of intracellular calcium and plasma renin by dietary calcium in menPETROV, V; LIJNEN, P.American journal of hypertension. 1999, Vol 12, Num 12, pp 1217-1224, issn 0895-7061, 12Article

Blood pressure and cationic transport systems during combined calcium channel blocker and calcium administration in malesLIJNEN, P; PETROV, V.Methods and findings in experimental and clinical pharmacology. 1996, Vol 18, Num 4, pp 287-294, issn 0379-0355Article

Cell membrane cation transport systems during aldosterone antagonismLIJNEN, P; PETROV, V.Journal of cardiovascular pharmacology. 1996, Vol 27, Num 4, pp 462-468, issn 0160-2446Article

Dietary calcium, blood pressure and cell membrane cation transport systems in malesLIJNEN, P; PETROV, V.Journal of hypertension. 1995, Vol 13, Num 8, pp 875-882, issn 0263-6352Article